(Q72561601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137255%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137255%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Propranolol in Schizophrenia: A Double Blind, Placebo Controlled Trial of Propranolol as an Adjunct to Neuroleptic Medication (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

12 August 2023

1 reference

1 reference

C. R. Pugh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6137255

12 August 2023

J. Steinert

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6137255

12 August 2023

R. G. Priest

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6137255

12 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6137255

12 August 2023

publication date

1 August 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137255%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

27 October 2019

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000117052

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

British Journal of Psychiatry

12 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137255%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137255%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

151-155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137255%20AND%20SRC:MED&resulttype=core&format=json

Some clinical and metabolic aspects of propranolol in chronic schizophrenia

27 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine

12 August 2023

3

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Prediction of Successful Rehabilitation by Nurse Rating Scale

12 August 2023

4

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Diagnostic Criteria for Use in Psychiatric Research

12 August 2023

6

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Psychosis with Ordinary Doses of Propranolol

12 August 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients

12 August 2023

8

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

THE NURSES' OBSERVATION SCALE FOR INPATIENT EVALUATION: A NEW SCALE FOR MEASURING IMPROVEMENT IN CHRONIC SCHIZOPHRENIA

12 August 2023

9

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Two patients with schizophrenic-like psychosis after treatment with beta-adrenergic blockers

12 August 2023

10

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

A comprehensive psychopathological rating scale

12 August 2023

11

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

CNS effects of propranolol in man

12 August 2023

15

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Active and Passive Avoidance Learning in Controls and Schizophrenic Patients on Racemic Propranolol and Neuroleptics

12 August 2023

16

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor

12 August 2023

18

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

A trial of propranolol in chronic schizophrenia

12 August 2023

20

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo

12 August 2023

22

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

12 August 2023

Propranolol psychosis

25

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Propranolol as an adjunct to the treatment of schizophrenia

12 August 2023

28

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

DL-propranolol and chlorpromazine following admission for schizophrenia. A controlled comparison

12 August 2023

29

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Propranolol in Chronic Schizophrenia: A Controlled Study in Neuroleptic-Treated Patients

12 August 2023

30

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

Propranolol uptake into the central nervous system and the effect on rat behaviour and amine metabolism.

12 August 2023

31

1 reference

https://api.crossref.org/works/10.1192/BJP.143.2.151

12 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137255%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference